Phase 3 Readout~month

Phase 3 Topline: HELIOS: An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC

Indication
Erythropoietic Protoporphyria

Other upcoming events for IRON

Phase 3 ReadoutPhase 3 Topline: APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy,
Phase 2 ReadoutPhase 2 Readout: disc-3405

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: HELIOS: An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC — IRON Phase 3 Readout | BioSniper